Denosumab May Offer Better Fracture Protection for Dialysis Patients

(MedPage Today) -- Dialysis patients on denosumab (Prolia, Xgeva) had a lower risk for fracture but higher risk for a certain heart event, suggested an observational trial weighted to emulate a clinical trial.
Among 1,032 Japanese patients on...